567 related articles for article (PubMed ID: 21320609)
21. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.
Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070
[TBL] [Abstract][Full Text] [Related]
22. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B
J Neurol Sci; 2008 Jan; 264(1-2):9-17. PubMed ID: 17727889
[TBL] [Abstract][Full Text] [Related]
23. State-associated changes in longitudinal [
De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
[TBL] [Abstract][Full Text] [Related]
24. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
[TBL] [Abstract][Full Text] [Related]
26. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
Ikawa M; Lohith TG; Shrestha S; Telu S; Zoghbi SS; Castellano S; Taliani S; Da Settimo F; Fujita M; Pike VW; Innis RB;
J Nucl Med; 2017 Feb; 58(2):320-325. PubMed ID: 27856631
[TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
[TBL] [Abstract][Full Text] [Related]
28. Characterization of 3 Novel Tau Radiopharmaceuticals,
Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
[No Abstract] [Full Text] [Related]
29. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
Gershen LD; Zanotti-Fregonara P; Dustin IH; Liow JS; Hirvonen J; Kreisl WC; Jenko KJ; Inati SK; Fujita M; Morse CL; Brouwer C; Hong JS; Pike VW; Zoghbi SS; Innis RB; Theodore WH
JAMA Neurol; 2015 Aug; 72(8):882-8. PubMed ID: 26052981
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of [
Nag S; Krasikova R; Airaksinen AJ; Arakawa R; Petukhovd M; Gulyas B
Bioorg Med Chem Lett; 2019 Aug; 29(16):2270-2274. PubMed ID: 31257082
[TBL] [Abstract][Full Text] [Related]
31. Kinetic Modeling of the Tau PET Tracer
Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D
J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967
[No Abstract] [Full Text] [Related]
32. Exploratory human PET study of the effectiveness of (11)C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer's disease.
Ohnishi A; Senda M; Yamane T; Mikami T; Nishida H; Nishio T; Akamatsu G; Ikari Y; Kimoto S; Aita K; Sasaki M; Shinkawa H; Yamamoto Y; Shukuri M; Mawatari A; Doi H; Watanabe Y; Onoe H
Nucl Med Biol; 2016 Jul; 43(7):438-44. PubMed ID: 27183464
[TBL] [Abstract][Full Text] [Related]
33. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Olgart Höglund C; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Brain Behav Immun; 2016 May; 54():149-157. PubMed ID: 26820224
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
[TBL] [Abstract][Full Text] [Related]
35. Effect of overnight smoking abstinence on a marker for microglial activation: a [
Brody AL; Gehlbach D; Garcia LY; Enoki R; Hoh C; Vera D; Kotta KK; London ED; Okita K; Nurmi EL; Seaman LC; Mandelkern MA
Psychopharmacology (Berl); 2018 Dec; 235(12):3525-3534. PubMed ID: 30343364
[TBL] [Abstract][Full Text] [Related]
36. PET imaging of [
Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409
[TBL] [Abstract][Full Text] [Related]
37. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
Biechele G; Blume T; Deussing M; Zott B; Shi Y; Xiang X; Franzmeier N; Kleinberger G; Peters F; Ochs K; Focke C; Sacher C; Wind K; Schmidt C; Lindner S; Gildehaus FJ; Eckenweber F; Beyer L; von Ungern-Sternberg B; Bartenstein P; Baumann K; Dorostkar MM; Rominger A; Cumming P; Willem M; Adelsberger H; Herms J; Brendel M
Theranostics; 2021; 11(18):8964-8976. PubMed ID: 34522221
[TBL] [Abstract][Full Text] [Related]
38. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.
Gouilly D; Saint-Aubert L; Ribeiro MJ; Salabert AS; Tauber C; Péran P; Arlicot N; Pariente J; Payoux P
Eur J Neurosci; 2022 Mar; 55(5):1322-1343. PubMed ID: 35083791
[TBL] [Abstract][Full Text] [Related]
39. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
[TBL] [Abstract][Full Text] [Related]
40. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography.
Dollé F; Luus C; Reynolds A; Kassiou M
Curr Med Chem; 2009; 16(22):2899-923. PubMed ID: 19689272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
